About: The use of coiled-coil proteins in drug delivery systems

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The use of coiled-coil proteins in drug delivery systems Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	The use of coiled-coil proteins in drug delivery systems
Creator	Stetefeld, Jörg Mcfarlane, Ainsley Orriss, George
Source	Elsevier; Medline; PMC
abstract	Abstract The coiled-coil motif is found in approximately 10% of all protein sequences and is responsible for the oligomerization of proteins in a highly specific manner. Coiled-coil proteins exhibit a large diversity of function (e.g. gene regulation, cell division, membrane fusion, drug extrusion) thus demonstrating the significance of oligomerization in biological systems. The classical coiled-coil domain comprises a series of consecutive heptad repeats in the protein sequence that are readily identifiable by the location of hydrophobic residues at the ‘a’ and ‘d’ positions. This gives rise to an α-helical structure in which between 2 and 7 helices are wound around each other in the form of a left-handed supercoil. More recently, structures of coiled-coil domains have been solved that have an 11 residue (undecad) or a 15 residue (pentadecad) repeat, which show the formation of a right-handed coiled-coil structure. The high stability of coiled coils, together with the presence of large internal cavities in the pentameric coiled-coil domain of cartilage oligomerization matrix protein (COMPcc) and the tetrameric right-handed coiled coil of Staphylothermus marinus (RHCC) has led us and others to look for therapeutic applications. In this review, we present evidence in support of a vitamin A and vitamin D3 binding activity for the pentameric COMPcc molecule. In addition, we will discuss exciting new developments which show that the RHCC tetramer is capable of binding the major anticancer drug cisplatin and the ability to fuse it to an antigenic epitope for the development of a new generation of vaccines.
has issue date	2009-12-25(xsd:dateTime)
bibo:doi	10.1016/j.ejphar.2009.05.034
bibo:pmid	19835864
has license	els-covid
sha1sum (hex)	5f79398d17ad6a77012eeff897057f3a199eb200
schema:url	https://doi.org/10.1016/j.ejphar.2009.05.034
resource representing a document's title	The use of coiled-coil proteins in drug delivery systems
has PubMed Central identifier	PMC7094320
has PubMed identifier	19835864
schema:publication	European Journal of Pharmacology
resource representing a document's body	covid:5f79398d17ad6a77012eeff897057f3a199eb200#body_text
is schema:about of	named entity 'cisplatin' named entity 'protein' named entity 'solved' named entity 'sequences' named entity 'oligomerization' named entity 'wound' named entity 'antigenic' named entity 'tetramer' named entity 'More' named entity 'right-handed' named entity 'biological systems' named entity 'developments' named entity 'hydrophobic' named entity 'Coiled-coil' named entity 'activity' named entity 'cavities' named entity 'gene' named entity 'structure' named entity 'residue' named entity 'coiled coil' named entity 'hydrophobic residues' named entity 'oligomerization' named entity 'matrix protein' named entity 'protein sequences' named entity 'tetramer' named entity 'supercoil' named entity 'coiled-coil structure' named entity 'vitamin' named entity 'biological systems' named entity 'drug delivery' named entity 'hydrogen bonds' named entity 'carcinoma' named entity 'drug delivery' named entity 'salt bridges' named entity 'left-handed' named entity 'protein' named entity 'vitamin' named entity 'matrix protein' named entity 'crystal structure' named entity 'Pauling' named entity 'heptad repeat' named entity 'vesicles' named entity 'coiled coil' named entity 'coiled coil' named entity 'ligand binding' named entity 'D 3' named entity 'hydrophobic core' named entity 'protein' named entity 'coiled coil' named entity 'homooligomer' named entity 'Gln' named entity 'polypeptide' named entity 'therapeutic antibodies' named entity 'α-helix' named entity 'protein' named entity 'coiled-coil' named entity 'Whitby' named entity 'coiled coil' named entity 'cytotoxicity' named entity '2.0' named entity 'epitope' named entity 'nanotechnology' named entity '7/2' named entity 'Homo sapiens' named entity 'coiled coil' named entity 'salt bridges' named entity 'hydrophobic residues' named entity 'VASP' named entity 'hydrophobic core' named entity 'helical' named entity 'muscle fibres' named entity 'hydrophobic' named entity 'chemotherapeutic drugs' named entity 'targeted drug delivery' named entity 'left-handed' named entity 'coiled coil' named entity 'Nooren' named entity 'molecule' named entity 'amino acid residues'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software